EHP Funds Inc’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-125,186
Closed -$7.01K – 290
2023
Q3
$7.01K Hold
125,186
– – ﹤0.01% 244
2023
Q2
$17.4K Hold
125,186
– – ﹤0.01% 229
2023
Q1
$10.6K Hold
125,186
– – ﹤0.01% 283
2022
Q4
$6K Sell
125,186
-12,090
-9% -$618 ﹤0.01% 315
2022
Q3
$20K Buy
137,276
+11,071
+9% +$1.23K ﹤0.01% 356
2022
Q2
$18K Buy
+126,205
New +$23.6K ﹤0.01% 386

EHP Funds Inc's BIOSW Position: Q4 2023 in Review

EHP Funds Inc sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 125,186 shares — an estimated $7.01K sold.

EHP Funds Inc first reported a position in BIOSW in Q2 2022 and held it in 6 quarters. The position peaked at $20K in Q3 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • EHP Funds Inc reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • EHP Funds Inc sold 125,186 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $7.01K.
  • EHP Funds Inc first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 6 quarters.
  • EHP Funds Inc's BioPlus Acquisition Corp. Warrants position peaked at $20K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on EHP Funds Inc's 13F filing for Q4 2023, filed 14 Feb 2024.